Clinical trial
Botulinum Toxin A for the Treatment of Chronic Lumbar Back Pain
NCT00404417 · Walter Reed Army Medical Center, U.S. Fed · Unknown status
Key facts
| NCT number | NCT00404417 |
|---|---|
| Title | Botulinum Toxin A for the Treatment of Chronic Lumbar Back Pain |
| Official title | Botulinum Toxin A for the Treatment of Chronic Lumbar Back Pain: A Prospective Randomized Double-blind Placebo-controlled Crossover Study |
| Lead sponsor | Walter Reed Army Medical Center, U.S. Fed |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Chronic Low Back Pain |
| Intervention type | Drug |
| Interventions | Botulinum Toxin A / Placebo, Botulinum Toxin A / Botulinum Toxin A, Placebo / Botulinum Toxin A, Placebo / Placebo |
| Enrollment | 160 |
| Start date | Mar 1, 2007 |
| Primary completion | Feb 1, 2011 |
| Completion | Feb 1, 2011 |
| First posted | Nov 28, 2006 |
| Last update posted | Mar 2, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: